Etonogestrel and ethinyl estradiol combination

This classification denotes a combination contraceptive drug. The first component of this drug is etonogestrel, a therapeutic progestin with the molecular formula C22H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 304GTH6RNH, chemically known as 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)- but generally known as etonogestrel, which bears US NIH Compound Identifier 40976. European Medicines Agency schedules Etonogestrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07335MIG. The term ETONOGESTREL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules etonogestrel in its Anatomical Therapeutic Chemical (ATC) Classification. ETONOGESTREL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC1(C2(C(C3C(C4C(=CC(=O)CC4)CC3)C(=C)C2)CC1)CC)C#C. The second component of this drug is ethinyl estradiol, a therapeutic estradiol, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 423D2T571U. European Medicines Agency schedules Ethinyl estradiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07277MIG. Ethinylestradiol generally arises in the molecular formula C20H24O2. The term 'ethinylestradiol' is a European Medicines Agency European Public Assessment Report System designation. ETHINYLESTRADIOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC1(C2(C(C3C(CC2)c2c(CC3)cc(O)cc2)CC1)C)C#C.